Soon Y. Jang
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
QAL333's antitumor activity and predictive modeling: integrated transcriptomic-bioinformatic analysis reveals selective cytotoxicity and sensitivity determinants.
Journal: Scientific reports
Published: November 03, 2025
Estrogen receptor α regulates SVCT2 protein level in human breast cancer cells.
Journal: Scientific reports
Published: January 03, 2025
Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2.
Journal: Cell biochemistry and function
Published: April 21, 2023
Shikonin as an inhibitor of the LPS-induced epithelial-to-mesenchymal transition in human breast cancer cells.
Journal: International journal of molecular medicine
Published: June 12, 2015
Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha.
Journal: Biochemical and biophysical research communications
Published: June 01, 2015
Shikonin causes apoptosis by up-regulating p73 and down-regulating ICBP90 in human cancer cells.
Journal: Biochemical and biophysical research communications
Published: May 08, 2015
Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation.
Journal: Oncology reports
Published: February 26, 2014
Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor.
Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor.
Journal: International journal of oncology
Published: October 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026